Patent · US Active

Alpha-4 beta-7 heterodimer specific antagonist antibody

US8444981B2 · kind B2 · utility

8Cited by
3References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2010
Grant dateMay 21, 2013
Priority date—
Expiry dateDec 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.